Maternal Oxygen Administration for Fetal Distress II
Oxygen Inhalation Therapy, Labour, Fetal Distress
About this trial
This is an interventional prevention trial for Oxygen Inhalation Therapy
Eligibility Criteria
Inclusion Criteria:
at term (>37 weeks, <42 weeks), singleton, cephalic presentation, spontaneous or induced labor, normal labor, category I FHR tracings, 2 to 3 cm of cervical dilation in nulliparity, 1 to 2 cm of cervical dilation in multipara, informed consent.
Exclusion Criteria:
respiratory or cardiovascular disease, diabetes mellitus or insulin-treated gestational diabetes mellitus, hypertension or preeclampsia, oligohydramnios, fetal growth restriction, placental abruption, cephalopelvic disproportion, meconium-stained amniotic fluid, tachysystole, having received O2, uterine incision (myomectomy or perforation), anemia, fever, chorioamnionitis, tobacco or alcohol use, disorders in oxygen saturations, hypotension, uncomfortable with facemask.
Sites / Locations
- Department of Obstetrics and Gynecology, PLA Strategic Support Force Characteristic Medical Center
- Department of Obstetrics and Gynecology, Seventh Medical Center, Chinese PLA General Hospital
- Department of Obstetrics and Gynecology, Sixth Medical Center, Chinese PLA General Hospital
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
air, the first and second stage of labor
oxygen, the first and second stage of labor
Patients randomized to the group will receive room air. The therapy will continue until after delivery
Patients randomized to the group will receive oxygen administered by high flow facemask oxygen at 10 L/min oxygen. The therapy will continue until after delivery